Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Wall Street set for weak open on hedge fund-retail battle

Fri, 29th Jan 2021 12:22

* U.S. futures, European stocks drop 0.5-0.8%

* Dollar index eyes weekly gain

* GameStop price nearly doubles in U.S. pre-market

* Bitcoin jumps 14% after Elon Musk mention

By Carolyn Cohn

LONDON, Jan 29 (Reuters) - U.S. stock futures and European
stocks fell on Friday while the safe-haven dollar held its
ground as a Wall Street battle between hedge funds and retail
investors and a row in Europe over COVID-19 vaccine supply
cooled risk appetite.

Wall Street has been gripped by an assault by small traders
organising over online forums, such as Reddit, to force hedge
funds to reverse short positions - or bets that stocks would
fall - on companies such as GameStop and AMC
Entertainment.

The stand-off comes after central bank and government
stimulus have propelled stock markets to record highs in recent
weeks, encouraging involvement by retail investors.

"There's fear in terms of the volatility," said Derek
Halpenny, head of research for global markets at MUFG. "Specific
trades in pockets of the market can spread into the broader
market."

Shares in GameStop, AMC Entertainment and
BlackBerry plunged more than 40% on Thursday after
several online platforms imposed buying halts, but rebounded as
Robinhood and Interactive Brokers eased the restrictions on
Friday.

GameStop shares nearly doubled and AMC Entertainment was up
55% in U.S. pre-market trade.

"Any hedge fund will be carefully looking at all their
shorts after this week and regulators will look very carefully
at collective retail trading," Deutsche Bank analysts said.

S&P 500 futures recouped some ground in European
trade but were down 0.5% by 1138 GMT. Nasdaq 100 futures
fell 0.7% .

Britain's FTSE 100 index fell 0.8% and European
stocks dropped 0.7%.

VACCINE ROW

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca offered eight million more doses of its
COVID-19 vaccine to the European Union, after it unexpectedly
announced cuts in supplies last week. But the bloc said that was
far short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have also prolonged
lockdowns and delayed expectations of an economic rebound.

Barclays analysts, however, said that "institutional
positioning is not aggressive overall, and as long as vaccines
work and central banks stay put, buy-the-dip mentality should
continue".

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race

The U.S. dollar rose to its highest since mid-November
against the yen, and was steady against an index of
currencies, bringing its weekly rise to 0.4%. The euro
edged up 0.1% and the pound was steady.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc TSLA.O chief Elon Musk tagged the cryptocurrency
in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

World stocks fell 0.4% towards three-week
lows set in the previous session, and were heading for a weekly
fall of more than 2%.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1%, on course for a weekly loss of 4.4%.
Japan's Nikkei fell 1.9%, recording its first weekly
loss of the year.

The People's Bank of China (PBOC) injected 100 billion yuan
into the financial system on Friday, following a week of
reducing liquidity, which had sparked concerns the central bank
was in fact tightening monetary policy.

The extra money did little to loosen short-term money
markets, where rates rose for a fifth straight day and benchmark
overnight repo rates surged to their highest in
nearly six years.

Oil prices rose within recent ranges, with concerns caused
by the new coronavirus variants and slow vaccine rollouts
offsetting a cut in Saudi Arabian oil supply and falling U.S.
oil inventories.

Brent crude futures were up 0.88% at $56.02 a barrel
and U.S. crude futures rose 0.5% to $52.60 a barrel.

Gold benefited from demand for safer assets, rising
1.1%.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Richard Pullin, Ana Nicolaci da
Costa, William Maclean, Larry King)

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer.

Read more
18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

Read more
18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses.

Read more
18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with paclitaxel did not achieve its primary endpoints.

Read more
17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

Read more
17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

Read more
17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

Read more
17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

Read more
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.